Actual Medicinal Product (AMP) -
Nuvaxovid XBB.1.5 COVID-19 Vaccine (recombinant, adjuvanted) 5micrograms/0.5ml dose dispersion for injection multidose vials (Novavax UK Ltd)
Name Details
|
Current Name
Nuvaxovid XBB.1.5 COVID-19 Vaccine (recombinant, adjuvanted) 5micrograms/0.5ml dose dispersion for injection multidose vials
|
Start Date
19-02-2024
|
End Date
|
|
|
Abbreviated Name
Nuvaxovid XBB.1.5 COVID-19 Vaccine 0.5ml inj multidose vials
|
Start Date
19-02-2024
|
|
Summary
- Licensed Route
- Intramuscular
- Availability Restrictions
- Restricted Availability
- Licensing Authority
- Medicines - MHRA/EMA
- EMA Indicator
- EMA Monitoring
Codes
SNOMED Codes
|
Code
|
Start Date
|
End Date
|
| 42645911000001106 |
19-02-2024 |
|
Actual Medicinal Product Pack (AMPP) Information